Tracheopulmonary Myiasis

Tracheopulmonary myiasis means fly larvae (maggots) live inside the breathing tubes or lungs. The larvae may be in the trachea (windpipe), bronchi (main breathing tubes), or deeper in the air passages. This is very rare in humans, but it can happen when larvae enter the airway by aspiration (breathing them in) or when flies lay eggs near an air opening (for example, a neglected tracheostomy or infected wound near the airway). PMC+3PMC+3ASM Journals+3

Tracheopulmonary myiasis (also called airway myiasis) means fly larvae (maggots) are living inside the breathing passages, such as the trachea (windpipe) and/or the bronchi and lungs. It is rare, but it can be very dangerous because larvae, mucus, swelling, and bleeding can block airflow, trigger severe cough, or cause infection. Most cases happen when flies can reach a vulnerable area (poor hygiene, open wounds, tracheostomy site, serious illness, reduced self-care, or hospital/long-term care settings). Treatment is usually urgent removal of larvae by a trained clinician, not home treatment. PMC+3CDC+3Medscape+3

Another names

Tracheopulmonary myiasis is also called respiratory myiasis, tracheobronchial myiasis, bronchial myiasis, intratracheal myiasis, and sometimes pulmonary myiasis. These names depend on the exact place where the larvae are found (trachea, bronchi, or lungs). PMC+2PMC+2

Types

• By relationship with the human body: obligatory, facultative, and accidental myiasis. ASM Journals+2CDC+2

• By location in the airway: intratracheal (trachea), tracheobronchial (trachea + bronchi), bronchial (bronchi), and lower airway/pulmonary involvement. PMC+2PMC+2

Obligatory myiasis means the larvae need living tissue to grow, so they can cause more damage if they invade living areas. This pattern is described in medical overviews of myiasis and in reports of severe, tissue-feeding species. ASM Journals+2CFSPH+2

Facultative myiasis means the larvae usually grow in decaying material or infected tissue, but they can also infest humans if there is a foul-smelling wound or poor hygiene that attracts flies. This is a common explanation for many human myiasis cases, including around tracheostomy sites. CDC+2ScienceDirect+2

Accidental myiasis means eggs or larvae enter the body by accident, such as through contaminated food or inhalation/aspiration, and then they are found in an unusual site like the airway. Respiratory cases described as aspiration/foreign-body style events fit this idea. ASM Journals+2Turkish Journal of Pediatrics+2

Intratracheal myiasis means larvae are inside the trachea, which can irritate the airway and may lead to dangerous complications if not removed. Case reports describe intratracheal infestation and emphasize careful removal and airway protection. PMC+1

Bronchial (or tracheobronchial) myiasis means larvae are in the bronchi (and sometimes also the trachea). This can look like an unusual airway “foreign body” and is often found by bronchoscopy. Turkish Journal of Pediatrics+2PMC+2

Causes

1. Living in warm tropical/subtropical areas. Many myiasis cases happen more often where flies are common and weather supports fly breeding. Swiss Medical Weekly+1

2. Poor hygiene. Poor body and wound hygiene makes odors stronger and attracts flies to lay eggs. ASM Journals+1

3. Low socioeconomic conditions or overcrowding. These conditions can increase fly exposure and reduce safe wound/airway care. ASM Journals+1

4. Sleeping outdoors or without good protection from flies. More direct contact with flies increases the chance of eggs/larvae entering the nose or mouth. ASM Journals+1

5. Close contact with livestock or animal shelters. Some fly species that cause myiasis are linked with animals, and human risk can rise with animal exposure. Swiss Medical Weekly+1

6. Open wounds near the face or airway. Flies can lay eggs on wounds and body openings that smell of secretions. SAGE Journals+1

7. Tracheostomy (a breathing hole in the neck). A tracheostomy creates an airway opening, and poor site care can let flies deposit eggs near the opening. PMC+1

8. Neglected or poorly cleaned tracheostomy tube and dressing. Reports and reviews describe poor tracheostomy care as a key risk factor for tracheostomy-area myiasis and possible airway involvement. PMC+1

9. Being very old, weak, or dependent on others for care. Frailty and dependence can delay cleaning and early detection of infestation. ScienceDirect+1

10. Social isolation or poor caregiving support. Isolation can delay hygiene and wound care, which increases myiasis risk in general. ScienceDirect+1

11. Cancer (especially head/neck or ulcerating tumors). Cancer wounds can smell and bleed, which strongly attracts flies in many reported myiasis situations. ScienceDirect+1

12. Diabetes. Diabetes is repeatedly listed as a risk factor because infections and wounds can be more common and healing can be slower. ScienceDirect+1

13. Malnutrition. Poor nutrition can weaken the body and slow healing, making wounds and infection more likely. ScienceDirect+1

14. Long hospital stay or ICU care with reduced self-care. ICU reports describe myiasis occurring in very sick patients who cannot protect themselves from flies. Swiss Medical Weekly+1

15. Reduced consciousness (coma, heavy sedation, severe illness). When a person cannot swat flies away or report symptoms, egg laying and infestation can go unnoticed. ResearchGate+1

16. Foul-smelling nasal or mouth discharge (chronic infection). Strong odors from infected secretions can attract flies to body openings. SAGE Journals+1

17. Poor oral hygiene with mouth ulcers or infection. Mouth odors and ulcers are classic settings where flies may lay eggs, and larvae can then reach nearby areas. imagejournals.org+1

18. Aspiration (breathing in) eggs or larvae. Some respiratory cases are described like aspiration of an unusual “foreign body,” with larvae later found in the airway. Turkish Journal of Pediatrics+1

19. Living where tissue-invading fly species exist. Some species are obligate parasites and can cause severe myiasis; exposure risk depends on geography and flies present. CFSPH+1

20. Delayed medical care for cough/breathing symptoms. Because respiratory myiasis is rare, delays can happen, allowing larvae to persist until bronchoscopy finds them. PMC+2PMC+2

Symptoms

1. Cough. The airway lining becomes irritated by the moving larvae, so the body tries to cough them out. PMC+1

2. Wheezing. Larvae can partially block air flow and trigger spasm-like sounds similar to asthma. PMC+1

3. Shortness of breath. Breathing can feel hard when the airway is inflamed or partly blocked. PMC+1

4. Noisy breathing or stridor. If larvae are in the upper airway or trachea, airflow can become tight and noisy. PMC+1

5. Chest tightness or chest pain. Irritation and inflammation in the airways can cause discomfort. PMC+1

6. Coughing up blood (hemoptysis). Larvae can injure fragile airway tissue, leading to bleeding in some cases. Amegroups+1

7. Coughing up thick or foul-smelling sputum. Secondary infection and dead tissue can create bad-smelling mucus. ASM Journals+1

8. Fever. Fever may appear when there is secondary bacterial infection or strong inflammation. ResearchGate+1

9. Recurrent chest infection or pneumonia-like episodes. Larvae and obstruction can lead to repeated infection signs until the cause is removed. ResearchGate+1

10. A choking feeling. Some patients feel like something is stuck in the airway, similar to a foreign body. Turkish Journal of Pediatrics+1

11. Hoarse voice. Irritation near the upper airway can change the voice, especially if inflammation is near the larynx/trachea. DoveMed+1

12. Runny nose or foul nasal discharge (if upper airway is involved). When infestation starts in the nose, discharge and odor may occur and airway spread is a concern. PMC+1

13. Feeling of “movement” in the airway or throat. This is uncommon but can happen because larvae move and the lining is sensitive. PMC+1

14. Allergic-type reaction with high eosinophils (a blood finding that can match symptoms). Some bronchial cases link larval exposure with strong eosinophilic inflammation and breathing distress. PubMed+1

15. Low oxygen symptoms (restlessness, fast breathing). If breathing tubes are blocked or the lungs inflame, oxygen can drop and breathing rate can rise. PMC+1

Diagnostic tests

Physical Exam

1. General appearance and breathing effort check. A clinician looks for fast breathing, chest retractions, distress, and inability to speak full sentences, which can happen in airway problems. PMC+1

2. Vital signs (temperature, pulse, respiratory rate, blood pressure). Fever and fast breathing can suggest inflammation or infection related to airway infestation. Swiss Medical Weekly+1

3. Chest auscultation (listening with a stethoscope). Wheeze, reduced breath sounds, or crackles can appear when airways are irritated or infected. PMC+1

4. Inspection of nose, mouth, and tracheostomy site (if present). Finding larvae or eggs at a body opening (especially a tracheostomy) can give a strong clue and helps decide if deeper airway checks are needed. PMC+2Bangladesh Journals Online+2

Manual test

5. Cough assessment (what triggers it, and what comes out). The clinician may ask about coughing fits and whether anything unusual (like small moving larvae) was seen in sputum. PMC+1

6. Peak flow test (simple blowing test). This can show airflow limitation, which may occur if the airway is narrowed or irritated, even though it does not prove myiasis by itself. PMC+1

7. Spirometry (breathing function test). Spirometry measures how fast and how much air a person can blow out; obstruction patterns can support an airway problem that needs bronchoscopy. PMC+1

8. Walking tolerance check (simple exertion test). A short monitored walk can reveal breathlessness and oxygen drop during activity, which helps measure severity. PMC+1

Lab and Pathological

9. Complete blood count (CBC) with differential. Eosinophilia (high eosinophils) can appear in some myiasis-related airway inflammation, although it is not always present. PubMed+1

10. Inflammation markers (CRP/ESR). These tests can support infection or inflammation when symptoms look like pneumonia or bronchitis. ResearchGate+1

11. Sputum microscopy (looking under a microscope). If larvae or larval parts are coughed up, microscopy can help confirm that the material is from fly larvae. CDC+1

12. Sputum culture (bacterial/fungal). This checks for secondary infection, which can happen when tissue is irritated or damaged. Swiss Medical Weekly+1

13. Bronchoalveolar lavage (BAL) cytology. During bronchoscopy, fluid can be washed in and collected; cytology can show eosinophilic inflammation and sometimes clues suggesting larval exposure. PubMed+1

14. Larval identification by an expert lab (entomology/parasitology). Correctly identifying the larva helps understand the type (obligate/facultative) and possible exposure source; CDC-style references explain diagnostic identification of myiasis agents. CDC+1

Electrodiagnostic

15. Continuous oxygen saturation monitoring (sensor-based monitoring). Monitoring oxygen saturation helps detect worsening airway obstruction or lung involvement and guides urgent care decisions. PMC+1

16. Electrocardiogram (ECG) when severely short of breath. ECG can help check heart stress from low oxygen or severe illness, which is important in emergency airway cases. PMC+1

Imaging Tests

17. Chest X-ray. A chest X-ray can show infiltrates or complications like pneumonia, but it usually cannot “see” the larvae directly. Radiologyinfo.org+1

18. CT scan of the chest. CT can show airway blockage, infection patterns, or complications, and it helps plan bronchoscopy; many respiratory myiasis reports use CT to check lung involvement. PMC+2PMC+2

19. Bronchoscopy (endoscopic airway imaging). This is the key test in many cases because it allows direct viewing of the trachea/bronchi and removal/collection of larvae for confirmation. Turkish Journal of Pediatrics+2PMC+2

20. CT of sinuses/neck when upper-airway source is suspected. If infestation may start in the nose or nearby tissues, CT imaging can help check spread and rule out deeper involvement alongside chest imaging. PMC+1

Non-pharmacological treatments (therapies and others)

1. Emergency airway assessment and monitoring — Description: Doctors first check breathing rate, oxygen level, mental alertness, and signs of airway blockage. Purpose: Prevent sudden suffocation. Mechanism: Early detection lets the team act fast with oxygen, suction, bronchoscopy, or an emergency airway. CDC+1

2. Bronchoscopy-based larval removal (flexible bronchoscopy) — Description: A thin camera tube goes into the airway so clinicians can see and remove larvae using suction/forceps. Purpose: Remove the cause directly. Mechanism: Physical extraction clears blockage and reduces ongoing tissue injury. Medscape+1

3. Rigid bronchoscopy (when needed) — Description: A firmer scope under anesthesia can give stronger control for large numbers of larvae or heavy bleeding. Purpose: Safer removal in severe obstruction. Mechanism: Better airway control and stronger instruments reduce the risk of incomplete removal. Medscape+1

4. Airway suctioning and “toilet” (airway cleaning) — Description: Frequent suction removes mucus, blood, debris, and any remaining small larvae pieces. Purpose: Keep the airway open. Mechanism: Less material in the airway means less blockage and less infection risk. Medscape+1

5. Humidified oxygen (or ventilatory support if required) — Description: Oxygen is given, often with humidification, and severe cases may need assisted ventilation. Purpose: Maintain safe oxygen delivery. Mechanism: Supports gas exchange while the underlying obstruction/inflammation is treated. Medscape+1

6. Nebulized normal saline (airway hydration) — Description: Saline mist helps loosen thick secretions. Purpose: Make coughing/suction more effective. Mechanism: Hydrates mucus so it moves out more easily, lowering blockage risk. Medscape

7. Chest physiotherapy (CPT) — Description: Techniques like percussion, vibration, and positioning help move mucus upward. Purpose: Improve mucus clearance. Mechanism: Mechanical movement + gravity helps mobilize secretions for coughing or suction. Medscape

8. Controlled coughing and breathing techniques (guided by clinicians) — Description: When safe, patients are coached to cough effectively and breathe slowly. Purpose: Reduce panic and improve clearance. Mechanism: Better airflow patterns help push secretions outward without exhausting the patient. Medscape

9. Sedation/anesthesia support for procedures — Description: Removal often needs sedation or general anesthesia (especially rigid bronchoscopy). Purpose: Safety and comfort. Mechanism: Prevents sudden movement, improves procedure control, and protects the airway during extraction. Medscape+1

10. Imaging to map the problem (X-ray/CT when stable) — Description: Imaging helps identify obstruction, inflammation, pneumonia, or complications. Purpose: Guide the plan and check severity. Mechanism: Seeing the airway/lungs helps target bronchoscopy and supportive care. Medscape+1

11. Larvae identification (lab/parasitology when available) — Description: Removed larvae may be identified to understand the species. Purpose: Public health guidance and prevention. Mechanism: Knowing the fly type supports targeted environmental control. CDC+1

12. Wound/tracheostomy site cleaning if present — Description: If a tracheostomy or wound exists, it is cleaned daily and dressed properly. Purpose: Remove attraction for flies and stop reinfestation. Mechanism: Clean, covered tissue reduces odor/exudate that attracts flies. CDC+2PMC+2

13. Environmental fly control in the home/care facility — Description: Screens, safe waste disposal, cleaning, and pest control reduce fly exposure. Purpose: Prevent recurrence. Mechanism: Fewer flies means fewer eggs/larvae contact with vulnerable areas. CDC+1

14. Strict hand hygiene for caregivers — Description: Caregivers wash hands before/after airway care, wound care, suctioning, and feeding. Purpose: Reduce secondary infection. Mechanism: Limits bacterial transfer to damaged airway tissue. CDC

15. Isolation-style precautions if larvae are actively present — Description: Cover wounds, contain soiled dressings, and safely dispose waste. Purpose: Control spread in facilities. Mechanism: Prevents flies from accessing larvae sources and reduces contamination. CDC+1

16. Hydration support (oral/IV fluids depending on severity) — Description: Fluids are corrected if dehydration exists from fever, poor intake, or breathing distress. Purpose: Support mucus clearance and circulation. Mechanism: Proper hydration keeps secretions thinner and supports healing. CDC+1

17. Nutrition support (high-protein, high-calorie when needed) — Description: Malnourished or severely ill patients may need dietitian support or tube feeding. Purpose: Improve healing and immune response. Mechanism: Adequate energy and protein support tissue repair after injury/infection. CDC

18. Treat the underlying risk factor — Description: Manage coma/immobility, mental health barriers, alcoholism, uncontrolled diabetes, or neglected tracheostomy care. Purpose: Stop recurrence. Mechanism: Fixing the root cause removes the conditions flies exploit. PMC+2PMC+2

19. Follow-up bronchoscopy (when heavy infestation or recurrence risk) — Description: A repeat look may be done to confirm full removal. Purpose: Ensure the airway is clear. Mechanism: Detects hidden larvae/necrotic material before it causes another blockage. Medscape+1

20. Education plan for caregivers — Description: Teach daily cleaning, dressing changes, insect protection, and early warning signs. Purpose: Long-term prevention. Mechanism: Consistent care reduces fly contact and enables fast response to symptoms. CDC+1

Drug treatments

1. Ivermectin (STROMECTOL) — Description: An antiparasitic sometimes used off-label in some myiasis cases to help kill larvae or reduce activity, but removal is still primary. Class: Anthelmintic. Typical label dosing: Depends on the approved infection and body weight (not a “myiasis home dose”). Purpose: Adjunct to removal in selected cases. Mechanism: Disrupts parasite nerve/muscle function. Side effects: Can include dizziness, GI upset, rash; serious reactions are possible. FDA Access Data+1

2. Albendazole (ALBENZA) — Description: Broad antiparasitic mainly used for specific worm diseases; in airway myiasis it may be considered only by specialists and is not the main cure. Class: Benzimidazole anthelmintic. Typical label dosing: Weight-based and indication-specific on the label. Purpose: Possible adjunct in selected parasitic contexts. Mechanism: Blocks parasite microtubule function and energy use. Side effects: Liver enzyme rise, GI upset, low blood counts (rare). FDA Access Data

3. Amoxicillin/clavulanate (AUGMENTIN) — Description: If there is secondary bacterial infection (cellulitis, pneumonia, foul discharge), clinicians may choose antibiotics based on exam/culture. Class: Penicillin + beta-lactamase inhibitor. Dosage/time: Label dosing varies by formulation/age and infection type; clinician-directed. Purpose: Treat bacterial coinfection. Mechanism: Blocks bacterial cell wall; clavulanate protects amoxicillin. Side effects: Diarrhea, rash, allergy, C. difficile risk. FDA Access Data+1

4. Clindamycin (CLEOCIN HCl) — Description: Useful when anaerobes or skin/soft tissue bacteria are suspected, especially around a tracheostomy site infection. Class: Lincosamide antibiotic. Dosage/time: Label dosing depends on infection severity and patient factors. Purpose: Treat bacterial infection and reduce complications. Mechanism: Inhibits bacterial protein synthesis. Side effects: Diarrhea and C. difficile colitis risk is important. FDA Access Data+1

5. Ceftriaxone (ROCEPHIN) — Description: A hospital IV antibiotic sometimes used for severe pneumonia or systemic infection when clinicians need broad coverage. Class: 3rd-generation cephalosporin. Dosage/time: Label dosing varies by infection and age/weight. Purpose: Treat serious bacterial infection complications. Mechanism: Blocks bacterial cell wall synthesis. Side effects: Allergy, diarrhea, biliary sludging (some cases). FDA Access Data+1

6. Azithromycin (ZITHROMAX) — Description: May be used when atypical pneumonia pathogens are suspected or as part of a clinician-chosen regimen. Class: Macrolide antibiotic. Dosage/time: Label regimens vary by diagnosis/age. Purpose: Treat bacterial respiratory coinfection when appropriate. Mechanism: Inhibits bacterial protein synthesis. Side effects: GI upset; QT-prolongation risk in susceptible patients. FDA Access Data+1

7. Doxycycline — Description: A tetracycline antibiotic sometimes chosen for skin/respiratory bacterial coverage in selected patients (clinician decision). Class: Tetracycline antibiotic. Dosage/time: Label dosing depends on condition and age; not for young children in many situations unless clinician decides. Purpose: Treat bacterial coinfection. Mechanism: Inhibits bacterial protein synthesis. Side effects: Photosensitivity, GI upset, esophagitis risk. FDA Access Data+1

8. Metronidazole (FLAGYL) — Description: Considered when anaerobic infection is suspected (foul-smelling discharge, necrotic tissue) in complex head/neck or wound situations. Class: Nitroimidazole antibiotic/antiprotozoal. Dosage/time: Label regimens vary by diagnosis. Purpose: Treat anaerobic bacterial involvement. Mechanism: Damages microbial DNA in anaerobes. Side effects: Metallic taste, nausea; avoid alcohol due to reactions. FDA Access Data+1

9. Levofloxacin (LEVAQUIN) — Description: Sometimes used for certain pneumonias when clinicians judge benefits outweigh risks. Class: Fluoroquinolone antibiotic. Dosage/time: Label dosing depends on diagnosis and kidney function. Purpose: Treat bacterial pneumonia/complications. Mechanism: Inhibits bacterial DNA replication enzymes. Side effects: Tendon injury risk, nerve effects, QT issues (important cautions). FDA Access Data+1

10. Ondansetron (ZOFRAN) — Description: Helps control nausea/vomiting during severe illness or after procedures/anesthesia. Class: 5-HT3 antiemetic. Dosage/time: Label dosing varies by age and indication. Purpose: Prevent dehydration and aspiration risk from vomiting. Mechanism: Blocks serotonin signaling that triggers vomiting. Side effects: Headache, constipation; QT risk in some patients. FDA Access Data+1

11. Acetaminophen IV (OFIRMEV) — Description: Used in hospitals to reduce fever and pain when oral intake is poor. Class: Analgesic/antipyretic. Dosage/time: Label dosing depends on weight/age and total daily acetaminophen from all sources. Purpose: Comfort, lower fever, reduce stress breathing. Mechanism: Central pain/fever pathway effects. Side effects: Liver toxicity if total dose exceeded. FDA Access Data

12. Ibuprofen IV (CALDOLOR) — Description: Hospital option for pain/fever control when clinicians need an NSAID. Class: NSAID. Dosage/time: Label dosing depends on indication and patient risk factors. Purpose: Reduce inflammation-related discomfort and fever. Mechanism: COX inhibition lowers prostaglandins. Side effects: GI bleeding, kidney injury, cardiovascular risks (boxed warnings). FDA Access Data+1

13. Ketorolac (TORADOL / ketorolac tromethamine) — Description: Strong short-term NSAID sometimes used for acute pain in monitored settings. Class: NSAID. Dosage/time: Label limits total duration (short course) due to serious risks. Purpose: Pain control after procedures. Mechanism: COX inhibition. Side effects: GI bleeding, kidney injury, cardiovascular risk; not for prolonged use. FDA Access Data+1

14. Lidocaine (XYLOCAINE) — Description: Local anesthetic used to numb airway during bronchoscopy or to reduce strong gag/cough reflex during procedures. Class: Amide local anesthetic. Dosage/time: Procedure-specific clinician dosing. Purpose: Safer airway procedures and comfort. Mechanism: Blocks sodium channels to stop pain signals. Side effects: Can affect heart/CNS if excessive systemic absorption occurs. FDA Access Data+1

15. Albuterol inhaler (VENTOLIN HFA) — Description: Helps open airways if bronchospasm/wheezing occurs alongside irritation and infection. Class: Short-acting beta-2 agonist bronchodilator. Dosage/time: Label dosing is inhalation-based; clinician decides frequency in acute illness. Purpose: Relieve tight airways and improve airflow. Mechanism: Beta-2 stimulation relaxes airway smooth muscle. Side effects: Tremor, fast heartbeat, anxiety. FDA Access Data+1

16. Ipratropium (ATROVENT HFA) — Description: Sometimes added for extra bronchodilation and secretion control in selected patients. Class: Anticholinergic bronchodilator. Dosage/time: Label dosing is inhalation-based; clinician guided. Purpose: Reduce bronchospasm and improve breathing comfort. Mechanism: Blocks muscarinic receptors → less airway tightening. Side effects: Dry mouth, blurred vision if sprayed into eyes. FDA Access Data+1

17. Acetylcysteine (mucolytic acetylcysteine products) — Description: In some settings, acetylcysteine is used as a mucolytic to thin thick mucus plugs, which may worsen obstruction around larvae/debris. Class: Mucolytic/antioxidant. Dosage/time: Product- and route-specific; clinician decides. Purpose: Improve secretion clearance. Mechanism: Breaks disulfide bonds in mucus, making it less sticky. Side effects: Bronchospasm in sensitive patients; irritation. FDA Access Data+1

18. Budesonide nebulizer (PULMICORT RESPULES) — Description: An inhaled steroid sometimes used to calm airway inflammation after irritation and procedures (clinician decision). Class: Inhaled corticosteroid. Dosage/time: Label dosing depends on age and asthma regimen; in acute airway injury it is specialist-directed. Purpose: Reduce swelling that narrows airways. Mechanism: Lowers inflammatory signaling in airway lining. Side effects: Oral thrush/hoarseness; systemic steroid effects are usually less than oral but still possible. FDA Access Data+1

19. Dexamethasone injection — Description: A systemic steroid clinicians sometimes use short-term for severe airway swelling, especially around procedures or intense inflammation. Class: Corticosteroid. Dosage/time: Label dosing varies widely by indication; clinician-directed. Purpose: Reduce airway edema and inflammation risk. Mechanism: Strong anti-inflammatory effect on immune signaling. Side effects: High sugar, mood changes, infection risk with higher/longer dosing. FDA Access Data+1

20. Prednisone (RAYOS is a prednisone product) — Description: Oral steroid sometimes used when inflammation is significant and a clinician judges benefit > risk. Class: Corticosteroid. Dosage/time: Label dosing depends on condition; tapering may be needed. Purpose: Reduce airway inflammation after removal/irritation. Mechanism: Decreases inflammatory mediators and immune overreaction. Side effects: Increased infection risk, high blood sugar, stomach upset, mood changes. FDA Access Data+1

Dietary molecular supplements

1. Protein (food first; supplement if intake is low) — Description: Healing after airway injury and infection needs enough protein daily. Dosage: Prefer food (eggs, fish, lentils, milk); if supplement is used, follow product label and clinician advice. Function: Tissue repair support. Mechanism: Provides amino acids for rebuilding damaged cells. CDC

2. Vitamin C — Description: Often used as a supportive nutrient during recovery, especially when diet is poor. Dosage: Stay near age-appropriate recommended intake unless a clinician advises otherwise. Function: Supports normal immune function and tissue repair. Mechanism: Works as an antioxidant and supports collagen-related repair. CDC

3. Vitamin D — Description: Helpful if deficient; many people have low levels. Dosage: Use safe, age-appropriate dosing; avoid high-dose self-treatment. Function: Immune support and general health. Mechanism: Helps regulate immune responses. CDC

4. Zinc — Description: Zinc supports normal immune function and may be useful when dietary zinc is low. Dosage: Avoid high doses unless prescribed. Function: Immune support. Mechanism: Supports many enzymes involved in immunity and repair. CDC

5. Selenium — Description: Trace mineral; best from food (fish, eggs, nuts) unless deficiency risk exists. Dosage: Avoid excessive supplements. Function: Antioxidant support. Mechanism: Needed for antioxidant enzymes. CDC

6. Omega-3 (EPA/DHA) — Description: Supports general inflammation balance and nutrition when intake is low. Dosage: Food (fish) preferred; supplement only if appropriate. Function: Support recovery nutrition. Mechanism: Omega-3 fats are used in cell membranes and inflammatory mediator balance. CDC

7. Probiotics — Description: Sometimes used when antibiotics disturb gut balance. Dosage: Follow product label; discuss with clinician (especially if immunocompromised). Function: Gut support during antibiotics. Mechanism: Helps maintain healthier gut microbiome balance. CDC+1

8. Oral rehydration salts (ORS) / electrolytes — Description: Useful if fever, poor intake, vomiting, or dehydration is present. Dosage: Follow ORS instructions and clinician advice. Function: Hydration support. Mechanism: Replaces water and salts needed for normal body function. CDC+1

9. N-acetylcysteine (NAC) (only if clinician agrees) — Description: NAC is related to acetylcysteine products used medically; some people take oral NAC, but it is not a direct cure for myiasis. Dosage: Follow clinician advice due to interactions/risks. Function: Support mucus/antioxidant pathways. Mechanism: Supports glutathione-related antioxidant systems and may influence mucus properties. FDA Access Data+1

10. Iron (only if deficiency is confirmed) — Description: Iron can help if blood tests show iron deficiency, especially after prolonged illness or poor diet. Dosage: Only with clinician guidance. Function: Restore healthy red blood cell production. Mechanism: Iron is required to carry oxygen in hemoglobin. CDC

Medicines immunity/regenerative/stem cell support

There are no standard “stem cell drugs” used to treat tracheopulmonary myiasis. The core treatment is removal of larvae plus supportive care. But in selected hospital situations, clinicians may use medicines that support airway lining recovery or control harmful inflammation. CDC+1

1. Palifermin (KEPIVANCE) — Description: A growth factor that helps epithelial cells grow; it is FDA-approved for specific mucosal injury settings (not myiasis). Dosage: Label-based and specialist-only. Function: Regenerative support of mucosal surfaces. Mechanism: Stimulates epithelial cell growth and repair. FDA Access Data

2. Becaplermin gel (REGRANEX) — Description: A topical growth factor for certain chronic ulcers; not an airway drug, but it shows how growth factors can support tissue healing (not a myiasis cure). Dosage: Label-based and condition-specific. Function: Tissue repair support. Mechanism: Promotes cell growth and wound repair pathways. FDA Access Data

3. Budesonide (inhaled steroid) — Description: Used to reduce inflammation in the airway lining when swelling is a major problem after irritation/procedures. Dosage: Label dosing depends on age/condition; clinician-directed. Function: Inflammation control. Mechanism: Suppresses inflammatory gene signaling in airway tissue. FDA Access Data+1

4. Prednisone (systemic steroid) — Description: Sometimes used short-term to control severe inflammation; can also increase infection risk, so it must be carefully chosen. Dosage: Clinician-directed. Function: Reduce harmful swelling and inflammation. Mechanism: Broad anti-inflammatory immune modulation. FDA Access Data+1

5. Dexamethasone (systemic steroid) — Description: A stronger steroid sometimes used in emergencies for airway swelling. Dosage: Clinician-directed; varies widely. Function: Rapid inflammation reduction. Mechanism: Potent suppression of inflammatory mediators. FDA Access Data+1

6. Acetylcysteine (mucolytic/antioxidant medical product) — Description: Used in some settings to help break thick mucus and support airway clearance (not an anti-larval drug). Dosage: Route-specific and clinician-directed. Function: Airway “cleaning” support. Mechanism: Breaks mucus bonds and supports antioxidant pathways. FDA Access Data+1

Surgeries/procedures

1. Flexible bronchoscopy extraction — Why: Directly removes larvae and debris while visualizing the airway. Medscape+1

2. Rigid bronchoscopy extraction — Why: Used when obstruction is severe, bleeding risk is high, or better airway control is needed under anesthesia. Medscape+1

3. Tracheostomy (or revision of an existing tracheostomy) — Why: Creates a secure airway when upper airway obstruction is critical, or to manage airway secretions safely; also may be needed if complications occur. PMC+1

4. Surgical debridement of necrotic tissue (if present) — Why: Removes dead/infected tissue that can harbor bacteria and attract flies, and helps healing after infestation. CDC+1

5. Repair of complications (example: fistula/airway reconstruction) — Why: Rarely, severe tissue destruction can cause abnormal connections or structural damage that must be repaired by specialists. SciSpace+1

Prevention steps

1. Keep all wounds (including tracheostomy sites) clean and covered. CDC+1

2. Do daily wound cleaning and dressing changes as instructed. CDC

3. Use window screens, bed nets when needed, and limit fly entry. CDC

4. Dispose of garbage properly and keep surroundings clean to reduce flies. CDC

5. If caregiving, maintain hand hygiene before/after care. CDC

6. Protect vulnerable patients (bed-bound, confused, critically ill) with regular skin and wound checks. PMC+1

7. Use EPA-registered insect repellent when exposure risk is high. CDC

8. Keep tracheostomy tubes and humidifiers clean per medical guidance. PMC+1

9. Treat underlying issues (malnutrition, poor hygiene access, neglected care needs) early. PMC+1

10. Seek care early for foul smell, discharge, or visible larvae—early treatment prevents deep infestation. CDC

When to see a doctor (go now vs soon)

Go to emergency care now if there is shortness of breath, choking, noisy breathing, coughing blood, chest pain, confusion, blue lips, or if larvae might be in the airway. See a doctor the same day for fever, foul-smelling wound/discharge, worsening cough, or any suspected myiasis, because proper diagnosis and removal are clinician procedures. CDC+1

What to eat and what to avoid

1. Eat: Protein foods (fish, eggs, dairy, lentils) to support repair; Avoid: very low-protein diets during recovery. CDC

2. Eat: Plenty of fluids (water/ORS if advised); Avoid: dehydration and excess caffeine if it worsens dehydration. CDC

3. Eat: Soft, warm foods if throat is sore after procedures; Avoid: very spicy/irritating foods if coughing worsens. Medscape

4. Eat: Fruits/vegetables for micronutrients; Avoid: mostly ultra-processed foods if appetite is low. CDC

5. Eat: Iron-rich foods if deficient; Avoid: taking iron pills without confirmed deficiency. CDC

6. Eat: Yogurt/fermented foods if tolerated during antibiotics; Avoid: probiotics if severely immunocompromised unless doctor agrees. FDA Access Data+1

7. Eat: Small frequent meals if nausea; Avoid: greasy heavy meals if vomiting. FDA Access Data

8. Eat: High-fiber foods if constipation from medicines; Avoid: ignoring constipation until severe. FDA Access Data+1

9. Eat: Adequate calories (energy) if underweight; Avoid: fasting while acutely ill unless medically required. CDC

10. Eat: Follow any swallowing plan if aspiration risk; Avoid: thin liquids if a clinician says thickened fluids are safer. Medscape

FAQs

1. Can tracheopulmonary myiasis go away by itself? Usually it needs clinician removal; waiting can be dangerous if the airway blocks. CDC+1

2. What is the main treatment? The main treatment is physical removal of larvae (often bronchoscopy) plus cleaning and supportive care. CDC+1

3. Do antibiotics kill the larvae? No, antibiotics treat bacteria, not larvae; they are used only if bacterial infection is suspected/confirmed. FDA Access Data+1

4. Does ivermectin always work? Ivermectin may help in some myiasis cases, but it is not a substitute for removal, and use is clinician-directed (often off-label). FDA Access Data+1

5. How do larvae reach the airway? Flies can deposit eggs/larvae near openings or neglected wounds; risk rises with poor hygiene, severe illness, or tracheostomy care problems. PMC+2PMC+2

6. Is it contagious person-to-person? Typically no; it’s usually related to fly exposure and wound/skin vulnerability, not direct spread like a cold. CDC+1

7. What complications can happen? Airway blockage, bleeding, pneumonia, tissue destruction, and rarely structural damage are possible, so prompt care matters. SciSpace+1

8. Why can cough get worse? Larvae and inflamed tissue irritate airway nerves and increase mucus production, triggering coughing spasms. Medscape

9. What tests are used? Clinicians use airway exam, bronchoscopy, and sometimes imaging (X-ray/CT) to assess obstruction and complications. Medscape+1

10. Can children get it? Yes, but it’s rare; risk increases with tracheostomy, severe disability, or poor hygiene access. PMC+1

11. How do you prevent recurrence? Clean/cover wounds, maintain tracheostomy hygiene, and reduce flies (screens, repellents, clean environment). CDC+2CDC+2

12. Is surgery always needed? Not always “open surgery,” but a procedure (often bronchoscopy) is commonly needed to remove larvae safely. Medscape+1

13. Can I try home remedies to pull larvae out? For airway cases, no—home attempts can worsen blockage or cause bleeding; clinicians should remove them. CDC+1

14. What medicines help symptoms while treating the cause? Hospitals may use bronchodilators, mucolytics, fever/pain control, and sometimes steroids—based on clinician judgment. FDA Access Data+3FDA Access Data+3FDA Access Data+3

15. What is the recovery like? After complete removal and good airway/wound care, many patients improve, but follow-up is important to confirm no remaining larvae and to manage complications. CDC+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 15, 2025.